These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23074006)

  • 1. Obesity and hormonal contraception: safety and efficacy.
    Edelman AB; Jensen JT
    Semin Reprod Med; 2012 Dec; 30(6):479-85. PubMed ID: 23074006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraception in obesity, the metabolic syndrome, and diabetes.
    Skouby SO
    Ann N Y Acad Sci; 2010 Sep; 1205():240-4. PubMed ID: 20840279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091.
    ; Higginbotham S
    Contraception; 2009 Dec; 80(6):583-90. PubMed ID: 19913155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal contraception and obesity.
    Simmons KB; Edelman AB
    Fertil Steril; 2016 Nov; 106(6):1282-1288. PubMed ID: 27565257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contraception and obesity].
    Lobert M; Pigeyre M; Gronier H; Catteau-Jonard S; Robin G
    Gynecol Obstet Fertil; 2015 Nov; 43(11):740-7. PubMed ID: 26527416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and contraception: emerging issues.
    Murthy AS
    Semin Reprod Med; 2010 Mar; 28(2):156-63. PubMed ID: 20352564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive use and sexual behavior in obese women.
    Kaneshiro B
    Semin Reprod Med; 2012 Dec; 30(6):459-64. PubMed ID: 23074003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of hormonal contraception for obese women.
    Rocha ALL; Campos RR; Miranda MMS; Raspante LBP; Carneiro MM; Vieira CS; Reis FM
    Expert Opin Drug Saf; 2017 Dec; 16(12):1387-1393. PubMed ID: 28988524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive use and contraception type in women by body mass index category.
    Schraudenbach A; McFall S
    Womens Health Issues; 2009; 19(6):381-9. PubMed ID: 19879452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women.
    Lotke PS; Kaneshiro B
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):647-57. PubMed ID: 26598306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J; Gompel A
    Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives.
    Burke AE
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S14-7. PubMed ID: 21961819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and contraception: metabolic changes, risk of thromboembolism, use of emergency contraceptives, and role of bariatric surgery.
    Gurney EP; Murthy AS
    Minerva Ginecol; 2013 Jun; 65(3):279-88. PubMed ID: 23689170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
    Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
    Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims.
    O'Brien SH; Klima J; Reed S; Chisolm D; Schwarz EB; Kelleher KJ
    Contraception; 2011 Feb; 83(2):134-7. PubMed ID: 21237338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors related to planned and unplanned pregnancies.
    Rosenfeld JA; Everett KD
    J Fam Pract; 1996 Aug; 43(2):161-6. PubMed ID: 8708626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The obese woman: pregnancy and contraception].
    Seffert P
    Lyon Mediterr Med Med Sud Est; 1985 Oct; 21(16):10179-80. PubMed ID: 12282289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.